Cytori Therapeutics Inc (NASDAQ:CYTX)

0.9505
Delayed Data
As of Jul 20
 -0.0245 / -2.51%
Today’s Change
0.91
Today|||52-Week Range
11.40
-68.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues5.0M4.8M4.7M2.7M
 
 
 
 
 
Cost of Goods Sold2.2M2.1M1.5M392.0K
 
 
 
 
 
Depreciation And Amortization779.0K1.1M1.2M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income2.0M1.7M1.9M146.0K
 
 
 
 
 
General Expenses37.5M31.4M28.4M22.9M
 
 
 
 
 
Research And Development15.1M19.0M16.2M11.7M
 
 
 
 
 
Total Operating Expenses40.4M34.6M31.1M25.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.5M-29.8M-26.4M-22.7M
 
 
 
 
 
Extraordinary Credit369.0K7.7M0.000.00
 
 
 
Extraordinary Charge0.00-260.0K0.00-1.7M
 
 
 
Interest Expense On Debt4.4M3.4M2.6M2.0M
 
 
 
 
 
Other Expenses2.1M7.0M7.0M3.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-37.4M-18.7M-22.0M-22.7M
 
 
 
 
 
Net Income-38.5M-19.4M-22.0M-26.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS538.9K938.6K1.7M3.2M
 
 
 
 
 
Shares To Calculate EPS Diluted538.9K938.6K1.7M3.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$72.00-$21.00-$12.80-$8.20
 
 
 
 
 
EPS Diluted-$72.00-$21.00-$12.80-$8.20